Coreo AG — Earnings Release 2010

Sep 21, 2010

News Details

Corporate | 21 September 2010 06:44

Nanostart AG announces record numbers for the first half of 2010

Nanostart AG / Key word(s): Miscellaneous

21.09.2010 06:44

Transparency report in accordance with §17 Section 2 of the general terms
and conditions for open markets

• Best first half of year in company history
• Net asset value increases to nearly EUR 144 million
• Cash influx from BioMicro transaction not yet included

Frankfurt am Main - September 21, 2010 - Frankfurt-based nanotechnology
company Nanostart AG is reporting the best first-half results since the
company was founded for the first six months of 2010. In accordance with
commercial code, semi-annual net profit totaled EUR 923,000 (previous year
EUR -1.4 million). Earlier in the year, Swiss company and global market
leader Roche Diagnostics purchased the main product line of American
Nanostart holding BioMicro Systems, Inc. Revenues from this transaction are
however not included in semi-annual numbers, as the cash transfer took
place after the June 30, 2010 reporting date.

In addition to positive earnings results, Nanostart achieved a net asset
value of nearly EUR 144 million as of the reporting date. This is
approximately EUR 29 million more than at the same point last year. In the
conservative calculation of net asset value, shares of unlisted
shareholdings - about 80 percent of the current portfolio - are attributed
to acquisition costs in the calculations. Only existing shareholdings in
Nanostart AG companies that are listed on the stock exchange are entered at
market value.

The company continues to pursue international expansion. Acquisition of
additional holdings is anticipated this year, especially in Singapore,
where Nanostart is investing as a government partner.

Semi-annual numbers are now archived at the Nanostart website in the
Investor Relations area. The 2010 semi-annual report will be available
September 27 in the company reports section.

About Nanostart:
Nanostart AG is the world's leading nanotechnology investment company. The
Frankfurt-based company provides venture capital financing for
nanotechnology companies in various growth phases. It also provides the
benefits of its experience and expertise to developers of financial
instruments and to investors in the nanotechnology sector. For further
information about the company, please visit www.nanostart.de.

Disclaimer:
This notice constitutes neither an offer to sell nor a solicitation of
offers to purchase or subscribe to securities. There will be no public
offering of securities of Nanostart AG in conjunction with the existing
listing of its shares in the 'Entry Standard' segment of the regulated
unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This
notice does not constitute a securities prospectus. Neither this notice nor
the information contained within is intended for direct or indirect
distribution within the United States of America, Canada, Australia or
Japan. If there is any inconsistency between the German and the English
versions of this document, the German version will prevail.

Media contact:
Nanostart AG
Public Relations
Dr. Hans Joachim Dürr
Goethestrasse 26-28
60313 Frankfurt
Germany
phone: +49 (0)69-21 93 96 111
fax: +49 (0)69-21 93 96 122
e-mail: presse@nanostart.de

21.09.2010 Dissemination of a Corporate News, transmitted by DGAP -
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---